We are live on
!
Find out more
ACM
Ashford Capital Management Portfolio holdings
AUM
$809M
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+10.63%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.15%
5 Year Est. Return
+109.93%
10 Year Est. Return
+1,281.06%
AUM
$898M
AUM Growth
+$46.6M
(+5.5%)
Cap. Flow
-$1.9M
Cap. Flow
% of AUM
-0.21%
Top 10 Holdings %
Top 10 Hldgs %
37.38%
Holding
117
New
15
Increased
24
Reduced
44
Closed
7
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dutch Bros
BROS
|
+$10.2M |
| 2 |
VIA
Via Transportation Inc
VIA
|
+$9.14M |
| 3 |
VOXR
Vox Royalty Corp
VOXR
|
+$8.78M |
| 4 |
Porch Group
PRCH
|
+$8.11M |
| 5 |
Cellebrite
CLBT
|
+$6.83M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ligand Pharmaceuticals
LGND
|
+$8.64M |
| 2 |
CYBR
CyberArk
CYBR
|
+$6.19M |
| 3 |
AXON
Axon Enterprise
AXON
|
+$5.67M |
| 4 |
Atlas Energy Solutions
AESI
|
+$5.49M |
| 5 |
StoneX
SNEX
|
+$4.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.88% |
| 2 | Healthcare | 16.79% |
| 3 | Financials | 11.81% |
| 4 | Industrials | 8.02% |
| 5 | Communication Services | 7.86% |
Similar funds
BDWCC
IPW
BWS
SSG
BBI
RPAM
PS
UAG
Ashford Capital Management's Q3 2025 Portfolio in Review
As of Q3 2025, Ashford Capital Management held 117 positions worth $898M, up 5.5% from $851M the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Ashford Capital Management's Q3 2025 filing shows 15 new, 24 increased, 44 reduced and 7 closed positions. Its largest new stake was Dutch Bros: 161,390 shares worth $8.45M. The largest sale was Ligand Pharmaceuticals, an estimated $8.64M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.
- Ashford Capital Management's largest Q3 2025 buy was Dutch Bros: 161,390 shares worth $8.45M.
- Ashford Capital Management added most to Cellebrite in Q3 2025, an estimated $6.83M increase.
- Ashford Capital Management's biggest Q3 2025 reduction was Ligand Pharmaceuticals, cutting an estimated $8.64M.
- Ashford Capital Management fully exited Goosehead Insurance in Q3 2025, selling an estimated $2.92M.
- Ashford Capital Management's ten largest holdings make up 37% of its $898M portfolio in Q3 2025.
- Ashford Capital Management opened 15 new positions and closed 7 in Q3 2025.
- Ashford Capital Management's portfolio value rose 5.5% quarter-over-quarter to $898M.
Based on Ashford Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.